1 terminated. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Terminated 1 |
Follow AB103: new trials by email Literature Review of AB103 trials Research Report on AB103
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase 3 Study of Reltecimod vs Placebo in Patients With Sepsis-associated Acute Kidney Injury Reltecimod 0.5 mg/kg, Placebo - Acute Kidney Injury, Peritonitis | Phase 3 | Terminated | Atox Bio Ltd | 58 | 2018-05-24 | 2021-10-12 |
Acute Kidney Injury (1) · Intraabdominal Infections (1) · Peritonitis (1)
Atox Bio Ltd (1)
France (1) · United States (1)
Azra Bihorac, MD (1)